| Issue Date | Title | Author(s) |
| 2014 | Effect of Eltrombopag on Platelet Response and Safety Results in Chinese Adults with Chronic ITP-Primary Result of a Phase III Study | Yang, Renchi; Hou, Ming; Li, Junmin; Jin, Jie; Huang, Meijuan; Yu, Ziqiang; Xu, Xiaojun; Zhang, Xiaohui; Du, Xin; Niu, Ting; Ke, Xiaoyan; Wang, Jianmin; Liu, Jing; Sun, Jing; Zhao, Yongqiang; Lu, Hua; Guo, Haiyi; Hsu, Belinda |
| 2018 | Efficacy and Safety of Eltrombopag in Chinese Patients with Chronic Immune Thrombocytopenia: Stage 2 Results from a Multicenter Phase III Study | Yang, Renchi; Liu Xiaofan; Li, Junmin; Hou, Ming; Jie, Jin; Huang, Meijuan; Yu, Ziqiang; Xu, Xiaojun; Zhang, Xiaohui |
| Nov-2020 | Efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia: stage 2 results from a multicenter phase III study | Liu, Xiaofan; Hou, Ming; Li, Junmin; Jin, Jie; Huang, Meijuan; Yu, Ziqiang; Xu, Xiaojun; Zhang, Xiaohui; Yang, Renchi |
| 2006 | Leptin enhances in vitro secretion of IgG antiplatelet antibodies by splenocytes and peripheral blood mononuclear cells from patients with chronic idiopathic thrombocytopenic purpura | Ren, He; Zhao, Hui; Wang, Tingting; Yang, Yanhui; Han, Zhibo; Liu, Bin; Wu, Zida; Tao, Jie; Zhou, Bin; Zhang, Lei; Yang, Renchi; Han, Zhong Chao |
| 2011 | microRNA regulation in megakaryocytopoiesis | Li, Huiyuan; Zhao, Haifeng; Wang, Donghai; Yang, Renchi |
| 2012 | A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia | Wang, Shujie; Yang, Renchi; Zou, Ping; Hou, Ming; Wu, Depei; Shen, Zhixiang; Lu, Xijing; Li, Yan; Chen, Xiequn; Niu, Ting; Sun, Hui; Yu, Li; Wang, Zhao; Zhang, Yin; Chang, Naibai; Zhang, Gaokui; Zhao, Yongqiang |
| 25-Feb-2021 | A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia | Mei, Heng; Liu, Xiaofan; Li, Yan; Zhou, Hu; Feng, Ying; Gao, Guangxun; Cheng, Peng; Huang, Ruibin; Yang, Linhua; Hu, Jianda; Hou, Ming; Yao, Yazhou; Liu, Li; Wang, Yi; Wu, Depei; Zhang, Liansheng; Zheng, Changcheng; Shen, Xuliang; Hu, Qi; Liu, Jing; Jin, Jie; Luo, Jianmin; Zeng, Yun; Gao, Sujun; Zhang, Xiaohui; Zhou, Xin; Shi, Qingzhi; Xia, Ruixiang; Xie, Xiaobao; Jiang, Zhongxing; Gao, Li; Bai, Yuansong; Li, Yan; Xiong, Junye; Li, Runzi; Zou, Jianjun; Niu, Ting; Yang, Renchi; Hu, Yu |
| 2017 | Multicentre, randomised phase III study of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia | Yang, Renchi; Li, Junmin; Jin, Jie; Huang, Meijuan; Yu, Ziqiang; Xu, Xiaojun; Zhang, Xiaohui; Hou, Ming |
| Jul-2023 | Romiplostim in primary immune thrombocytopenia that is persistent or chronic: phase III multicenter, randomized, placebo-controlled clinical trial in China | Zhou, Hu; Zhou, Jianfeng; Wu, Depei; Ma, Liping; Du, Xin; Niu, Ting; Yang, Renchi; Liu, Jing; Zhang, Feng; Shi, Qingzhi; Wang, Xiuli; Jing, Hongmei; Li, Junmin; Wang, Xin; Cui, Zhongguang; Zhou, Zeping; Hou, Ming; Shao, Zonghong; Jin, Jie; Li, Wenqian; Ren, Hanyun; Hu, Jianda; Shen, Jianliang; Liu, Li; Zeng, Yun; Zhou, Jin; Liu, Xin; Shen, Yunfeng; Ding, Kai; Taira, Tadaaki; Cai, Huacong; Zhao, Yongqiang |
| Jul-2023 | Romiplostim in primary immune thrombocytopenia that is persistent or chronic: phase III multicenter, randomized, placebo-controlled clinical trial in China | Zhou, Hu; Zhou, Jianfeng; Wu, Depei; Ma, Liping; Du, Xin; Niu, Ting; Yang, Renchi; Liu, Jing; Zhang, Feng; Shi, Qingzhi; Wang, Xiuli; Jing, Hongmei; Li, Junmin; Wang, Xin; Cui, Zhongguang; Zhou, Zeping; Hou, Ming; Shao, Zonghong; Jin, Jie; Li, Wenqian; Ren, Hanyun; Hu, Jianda; Shen, Jianliang; Liu, Li; Zeng, Yun; Zhou, Jin; Liu, Xin; Shen, Yunfeng; Ding, Kai; Taira, Tadaaki; Cai, Huacong; Zhao, Yongqiang |
